Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

10 mai 2018

08:35
DePuy Synthes*, part of the Johnson & Johnson Medical Devices Companies**, today announced clinical findings outlining the potential benefits patients may experience when undergoing knee replacement with the ATTUNE Knee System....

08:00
As the world marks Melanoma Awareness Month, the American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) selected the first group of scientists to receive newly established research grants to investigate how to reduce rare, but...

08:00
Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson's Stelara®, including 3-dimensional (3-D) structure confirmation through X-ray crystallography analysis. X-ray crystallography...

03:41
La société biopharmaceutique NeuClone a fait part de résultats précliniques positifs de son biosimilaire du Stelara® de Johnson & Johnson, comprenant une confirmation par analyse de cristallographie aux rayons X de la structure en 3 dimensions (3-D)....

03:00
Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson's Stelara®, including 3-dimensional (3-D) structure confirmation through X-ray crystallography analysis. X-ray crystallography...


9 mai 2018

11:11
Amid lectures and grading papers, one professor has helped engineer and test an antibody that has potential to treat the results of a multitude of vascular conditions, including pain in walking and limb necrosis associated with late-stage diabetes.  ...

08:30
Immunexpress, Inc. a annoncé aujourd'hui la publication, dans l'American Journal of Respiratory and Clinical Care Medicine, de la conception et des resultats d'essais cliniques validant SeptiCytetm LAB dans la discrimination de la septicémie du...

08:30
The Emmes Corporation today announced that scientists and health professionals from the company, LDS Hospital in Salt Lake City, Utah, Lovelace Biomedical Environmental Research Institute in Albuquerque, New Mexico, and the U.S. Army Medical and...

08:30
Immunexpress, Inc. today announced the publication in the American Journal of Respiratory and Clinical Care Medicine of the design and results of clinical trials validating SeptiCytetm LAB in the discrimination of sepsis from non-infectious systemic...

08:30
LyGenesis, Inc., a biotechnology company developing innovative technology for organ regeneration, announced today that they have raised $3 million in Series A financing from Juvenescence, Ltd. LyGenesis' technology uses lymph nodes as bioreactors to...

08:00
Array BioPharma Inc., today reported results for its third quarter of fiscal 2018 and provided an update on the progress of its key clinical development programs. "Preparations for the anticipated U.S. launch of encorafenib and binimetinib in...

07:30
Provention Bio, Inc., a clinical-stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics aimed at intercepting and preventing immune-mediated diseases, announced today that it has entered into...

07:30
Palatin Technologies, Inc. , a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential, announced today a poster presentation on...

04:10
Two researchers will share the 2018 Assar Gabrielsson award. The award for basic scientific research is presented to Britta Langen for her research about the mechanisms of radiation therapy. The award for clinical research is presented to Therese...

03:00
Biohaven Pharmaceutical Holding Company Ltd. today announced that it has established an expanded access program (EAP) with sublingual BHV-0223, an investigational drug candidate, for patients with amyotrophic lateral sclerosis (ALS).  Through this...

02:00
Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), and Servier, announced today that the pivotal Phase 3 (TAGS) trial evaluating LONSURF® (trifluridine and tipiracil) plus best supportive care (BSC) versus placebo...

01:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Chaim Lebovits, president and CEO, will present data from the company's Phase 2 clinical study of NurOwn® in...


8 mai 2018

18:33
Openwater is a healthcare company that is revolutionizing and minitiarizing the way we read and write our body and brain. After demonstrating a prototype working system at TED, Openwater announced today that it is ramping up to build developer kits....

16:20
SCYNEXIS, Inc. , a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today reported financial results for the quarter ended March 31, 2018, and provided an update on...

16:07
Infinity Pharmaceuticals, Inc. , a clinical-stage biotechnology company developing IPI-549, a first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma), announced today that data from the...

14:00
Neurocrine Biosciences, Inc. today announced new data from RE-KINECT, the largest real-world screening study to date of patients with clinician-confirmed possible tardive dyskinesia (TD), providing valuable insight into the impact of involuntary...

11:00
Researchers tissue-engineered human pancreatic islets in a laboratory that develop a circulatory system, secrete hormones like insulin and successfully treat sudden-onset type 1 diabetes in transplanted mice....

09:25
Alligator Bioscience , a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, and Aptevo Therapeutics Inc. , a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics,...

09:15
Creative Medical Technology Holdings announced today filing of patent application number 62663912 covering the use of its AmnioStemTM stem cells as a means of reducing/reversing natural aging.  Previous studies by the Company have demonstrated that...

09:02
Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients. The company also revealed initiation of a new clinical study...

09:00
DNAtrix, a leader in oncolytic virus immunotherapies for cancer, announced that Sonia Tejada, MD, PhD, neurosurgeon and investigator at Clínica Universidad de Navarra, will present data from an ongoing Phase 1 trial of DNX-2401 in pediatric patients...

08:30
Nektar Therapeutics  today announced that it has commenced dosing patients with systemic lupus erythematosus (SLE) in a Phase 1b clinical study evaluating NKTR-358, a first-in-class regulatory T cell stimulator. NKTR-358 selectively stimulates the...

08:12
Leadership from Quorum Review IRB and Kinetiq, the consulting and technology division of Quorum, have been invited, elected, or appointed to several key positions with clinical research initiatives, national trade organizations, and in respected...

08:00
Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for severe pulmonary diseases, will present data from the first cohort of its ongoing Phase 2 clinical trial, HOPE-1, in a late-breaking oral...

08:00
A recent study including single-cell transcriptome analysis has revealed an evolutionary model of chemoresistance in triple-negative breast cancer (TNBC) patients. This groundbreaking work, led by Professor Nicholas Navin (The University of Texas MD...

08:00
Florida Cancer Specialists & Research Institute (FCS) has been recognized by Blue Cross Blue Shield as a Blue Distinction® Center for Cancer Care. FCS is the only community hematology and oncology practice in the state of Florida to be awarded this...

08:00
Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Grouptm, a Swiss-based global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to...

07:56
Scientists at ONCE, in conjunction with two major US universities, have found that the addition of an Ultraviolet A (UV-A) spectrum into animal housing lighting reduces stress levels by a significant margin. This reduction of stress represents...

07:54
For the past several years, the renal anemia market has been rather sedate, with limited shifting in treatment rates or market share for erythropoietin stimulating agents (ESAs) and IV iron.  Changes are percolating, however, in both the dialysis and...

07:30
OncoSec Medical Incorporated (OncoSec) , a company developing intratumoral cancer immunotherapies, has entered a clinical trial collaboration and supply agreement with Merck (known as MSD outside the United States and Canada) to evaluate the...

07:00
Proteostasis Therapeutics, Inc. , a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, announced...

07:00
BCM-95®, a high-potency turmeric extract developed and manufactured by Arjuna Naturals Ltd., has been granted a patent for "composition for use in treatment" by the European Patent Office (EPO). This patent is in addition to 16 patents (13 in the US,...

07:00
GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced a research collaboration with Janssen Pharmaceuticals. As part of the agreement, GenomeDx will test samples using its genome-wide expression assay from multiple...

06:56
Researchers at Tokai University, Osaka University, Tohoku University and Fukuoka University report in the journal Communications Chemistry on the synthesis of insulin based on the self-assembly of polypeptide chains at about 40% efficiency. This new...

06:50
CollPlant , a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant human, "rhCollagen"), announced that it has filed a provisional patent application with the U.S. Patent...

06:00
A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG® radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40% lower incidence of silent acute cerebral embolism in atrial...

03:00
Debiopharm International SA (Debiopharm - www.debiopharm.com), membre de Debiopharm Grouptm, une société pharmaceutique basée en Suisse, a annoncé aujourd'hui que la Food and Drug Administration des États-Unis (FDA) a accordé la désignation...

03:00
Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Grouptm, a Swiss-based global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to...

03:00
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announces that the pivotal QuANTUM-R phase 3 study of single agent quizartinib met its primary endpoint of significantly prolonging overall survival compared to salvage chemotherapy in...


7 mai 2018

15:00
Northwell Health's Feinstein Institute for Medical Research Assistant Professor Theodoros P. Zanos, PhD, and his collaborators are the first to decode specific signals the nervous system uses to communicate immune status and inflammation to the...

11:26
AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare, debilitating childhood onset neurogenetic disorders with limited or no treatment options, today announced initiation of patient recruitment in an...

11:01
A review of nearly 500 cases of infants with severe congenital hyperinsulinism who underwent partial or near-total removal of their pancreas for persistent hypoglycemia at Children's Hospital of Philadelphia (CHOP) showed that surgeons can cure...

10:20
VentureMed Group, Inc., a medical device company specializing in the development and commercialization of innovative and cost-effective devices for the endovascular treatment of peripheral arterial disease (PAD), presented a technical review of the...

08:35
MabVax Therapeutics Holdings, Inc. , a clinical-stage oncology drug development company, today announced that the May 3rd presentation from David Hansen, MabVax's President and Chief Executive Officer, at VirtualInvestorConferences.com is now...

08:30
Neurotrope, Inc. , a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), is announcing that Neurotrope Bioscience, Inc., its wholly-owned operating subsidiary (the...